Agenus | AGEN - Trade Debtors


Agenus reported $22.34M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Agenus USD 22.34M 107K Mar/2026
Amgen USD 10.23B 1.09B Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Celldex Therapeutics USD 230K 0 Jun/2026
CSL USD 4.32B 1.35B Dec/2025
Eli Lilly USD 23.48B 2.3B Jun/2026
Gilead Sciences USD 5.06B 314M Jun/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
Glaxosmithkline GBP 10.49B 40.6M Mar/2026
Incyte USD 1.13B 73.7M Jun/2026
Intrexon USD 1.02M 559K Jun/2024
J&J USD 19.05B 3.49B Jun/2026
Jiangsu Hengrui CNY 6.62B 112.77M Jun/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Merck EUR 4.95B 139M Jun/2026
Merck USD 12.21B 435M Mar/2026
Northwest Biotherapeutics USD 311K 299K Sep/2025
Novartis USD 9.85B 252M Jun/2026
Novavax USD 106.45M 72.27M Dec/2025
Pfizer USD 16.19B 19M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Sangamo BioSciences USD 581K 110K Jun/2024
Veracyte USD 54.18M 4.06M Jun/2026